Going concern
Filing comparison
Radiopharm Theranostics Ltd disclosed substantial doubt about its ability to continue as a going concern
No substantial-doubt conclusion identified → Substantial doubt about ability to continue as a going concern
Going concern The accompanying financial statements have been prepared assuming that the Group will continue as a going concern. As discussed in Note 20(a)(iii) to the financial statements, the Group has suffered a total comprehensive loss of A$56,329,054 and net cash outflows from operations of A$52,782,838. These conditions, along with other matters as set forth in Note 20(a)(iii), raise substantial doubt about the Group’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 20(a)(iii). The financial statements do not include any…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- substantial_doubt
- Current state label
- Substantial doubt about ability to continue as a going concern
- Direction
- escalated
- Located in
- going-concern note
- Prior filed
- 2025-12-10
- Prior form
- 20-F/A
- Prior state
- none
- Prior state label
- No substantial-doubt conclusion identified
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.